Our researchers identified cellular genes as expression biomarkers for cervical dysplasia which can be used as a “molecular Pap test” having the potential to replace cytology in certain cervical cancer screening and diagnostic settings.
The company will offer a wide range of services including exome, transcriptome, and genome sequencing, and targeted sequencing on the Ion Proton and PGM platforms.
Learn more about our Services
We know what lab people like and we know what people outside labs need.
More about Cellcall
February 03, 2014
Continue Reading →